Grants & Awards 2013

September 2013

Anupam Agarwal, MD
UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research
National Institutes of Health
9/1/13 - 7/31/18

Ashita Tolwani, MD
NxStage Educational Grant – CRRT 2013
9/18/13 - 9/19/13


August 2013

Michal Mrug, MD
Mechanisms of C3 Effects in ARPKD Pathogenesis
National Institutes of Health
8/5/13 - 6/30/18

Dana Rizk, MD
A Single-Center Prospective Study Evaluating the FAST mGFR Test in Adults with Preserved Kidney Function and Impaired Kidney Function with Comparison to Lohexol Clearance Methods.
National Institutes of Health
8/23/13 - 2/22/14


June 2013

Dana Rizk, MD
A Double-Blind, Placebo-Controlled, Randomized, Two-Stage, Parallel-Group, Adaptive Design Phase 2a Study to Evaluate the Effects of BMS-813160 in Subjects with Type 2 Diabetes Mellitus and Diabetic Kidney Disease (DKD) Who have Residual Macroalbuminuria Despite Traatment with an Inhibitor of the Renin-Angiotensis System
6/5/13 - 6/4/16

Roslyn Mannon, MD
A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients
6/7/13 - 6/6/18

Roslyn Mannon, MD
A Randomized Open-Label, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Living Donor Kidney Transplant Recipients Requiring Desensitization Therapy
6/25/13 - 6/24/18


April 2013

Dana Rizk, MD
A Randomized Controlled Trial of Rituximub versis Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)
4/2/13 - 4/1/18


March 2013

David Warnock, MD
Annual Fabry Family Meeting 2013
3/1/13  - 3/31/13

Ashita Tolwani, MD
International Drug Induced Renal Injury Consortium (Direct)
3/15/13 - 3/14/15


January 2013

Denyse Thornley-Brown, MD
A Phase 2, Multicenter, Double Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients with Steroid Resistant Primary Focal Segmental Glomerulosclerosis
1/28/13 - 1/27/18